Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LusiNEX
- Development stage
- Phase 1
- Lead developer
- Gedeon Richter
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
LusiNEX is a biosimilar of tocilizumab, which is a recombinant humanized monoclonal antibody targeting the interleukin-6 receptor (IL-6R). By blocking both soluble and membrane-bound IL-6 receptors, LusiNEX inhibits IL-6-mediated pro-inflammatory signaling involved in numerous autoimmune and inflammatory conditions. Developed originally by Mycenax Biotech, it demonstrates bioequivalence to originator tocilizumab products Actemra (US) and RoActemra (EU), with indications for rheumatoid arthritis and potential for other immunologic and inflammatory diseases. It is being positioned as a more affordable alternative to the originator drug for global markets[2][3][4][5][7][9].
- Brand names
- LusiNEX
- Other names
- Mycenax tocilizumab biosimilar
02
Targets
IL-6R (Interleukin-6 receptor subunit alpha)
Beyond the preview
Go deeper on LusiNEX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LusiNEX.